EPIZYME Trademark Information

Trademark by Epizyme, Inc.

pharmaceutical products for the treatment of human diseases and disorders, namely, cancer, cell proliferative diseases and disorders, hematological diseases and disorders, and diseases and disorders driven by epigenetic mechanisms

pharmaceutical research and development in the fields of cancer, cell proliferative diseases and disorders, hematological diseases and disorders, genetic diseases and disorders, and diseases and disorders driven by epigenetic mechanisms; all of the foregoing for human medicinal purposes

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 1/30/2020
First Use In Commerce: 1/30/2020
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 9/1/2008
First Use In Commerce: 9/1/2008
General Information
Word mark: EPIZYME
Status/Status Date:
REGISTERED
2/9/2021
Serial Number: 88979999
Filing Date: 5/30/2019
Registration Number: 6268511
Registration Date: 2/9/2021
Goods and Services: pharmaceutical products for the treatment of human diseases and disorders, namely, cancer, cell proliferative diseases and disorders, hematological diseases and disorders, and diseases and disorders driven by epigenetic mechanisms
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 4/21/2020
Last Applicant/Owner:
Epizyme, Inc.
Cambridge, MA 02319
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
WOLF, GREENFIELD & SACKS, P.C.
600 ATLANTIC AVENUE
BOSTON, MA 02210
Current Status:
REGISTERED
2/9/2021
Correspondent Search:
Douglas R. Wolf is a correspondent of EPIZYME trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on